Počet záznamov: 1

tikagrelor

SYS		d000077486
LBL		00000cx^^^2200181-^^45^^
005		20240119195329.7
100		$a 20190101asloy0103 ba0
152		$b mesh
250		$a tikagrelor $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo
300	1-	$a 2019 (2005) $8 eng
330	1-	$a An adenosine triphosphate analogue and reversible P2Y12 PURINORECEPTOR antagonist that inhibits ADP-mediated PLATELET AGGREGATION. It is used for the prevention of THROMBOEMBOLISM by patients with ACUTE CORONARY SYNDROME or a history of MYOCARDIAL INFARCTION. $8 eng
450		$a Brilinta $5 e $8 slo
450		$a Brilique $5 e $8 slo
450		$a ticagrelor $5 e $8 slo
686		$a D03.633.100.759.590.138.806
686		$a D13.570.583.138.806
686		$a D13.570.800.096.815
750		$a Ticagrelor $8 eng
801	-0	$a SK $b BA006 $c 20190310
801	-2	$a SK $b BA006 $c 20190712
801	-2	$a SK $b BA006 $c 20190910
980		$x M

Počet záznamov: 1